News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
625,840 Results
Type
Article (24782)
Company Profile (160)
Press Release (600964)
Multimedia
Podcasts (43)
Webinars (13)
Section
Business (209458)
Career Advice (1109)
Deals (31757)
Drug Delivery (58)
Drug Development (70043)
Employer Resources (101)
FDA (13221)
Job Trends (11825)
News (304156)
Policy (25238)
Tag
2027 BioCapital Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (3)
Academia (1844)
Academic (1)
Accelerated approval (40)
ADA (32)
Adcomms (26)
Allergies (140)
Alliances (43125)
ALS (177)
Alzheimer's disease (1448)
Antibody-drug conjugate (ADC) (394)
Approvals (13805)
Artificial intelligence (525)
ASCO (245)
Autoimmune disease (271)
Automation (44)
Bankruptcy (303)
Best Places to Work (9430)
BIO (75)
BIOSECURE Act (7)
Biosimilars (177)
Biotechnology (97)
Bladder cancer (159)
Brain cancer (56)
Breast cancer (660)
Cancer (5004)
Cardiovascular disease (365)
Career advice (957)
Career pathing (30)
CAR-T (256)
CDC (32)
Celiac Disease (3)
Cell therapy (689)
Cervical cancer (48)
Clinical research (62385)
Collaboration (1721)
Commercialization (1)
Company closure (2)
Compensation (1413)
Complete response letters (58)
COVID-19 (1867)
CRISPR (88)
C-suite (1024)
Cystic fibrosis (121)
Data (7414)
Decentralized trials (1)
Denatured (22)
Depression (133)
Dermatology (84)
Diabetes (525)
Diagnostics (5763)
Digital health (52)
Diversity (9)
Diversity, equity & inclusion (33)
Drug discovery (260)
Drug pricing (94)
Drug shortages (20)
Duchenne muscular dystrophy (236)
Earnings (86706)
Editorial (33)
Employer branding (11)
Employer resources (97)
Events (106453)
Executive appointments (927)
FDA (16545)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (30)
Funding (1353)
Gene editing (172)
Generative AI (37)
Gene therapy (518)
GLP-1 (682)
Government (2626)
Grass and pollen (4)
Guidances (382)
Healthcare (14542)
Hematology (147)
HIV (78)
Huntington's disease (39)
IgA nephropathy (94)
Immunology and inflammation (176)
Immuno-oncology (77)
Indications (193)
Infectious disease (2164)
Inflammatory bowel disease (185)
Inflation Reduction Act (8)
Influenza (124)
Intellectual property (289)
Interviews (181)
IPO (14890)
IRA (23)
Job creations (2762)
Job search strategy (829)
JPM (22)
Kidney cancer (19)
Labor market (41)
Layoffs (231)
Leadership (30)
Legal (6524)
Liver cancer (66)
Longevity (24)
Lung cancer (691)
Lymphoma (385)
Machine learning (44)
Management (35)
Manufacturing (789)
Marketing (7)
MASH (172)
Medical affairs (1)
Medical device (11404)
Medtech (11548)
Mergers & acquisitions (18069)
Metabolic disorders (1169)
mRNA (110)
Multiple sclerosis (155)
NASH (15)
Neurodegenerative disease (345)
Neuropsychiatric disorders (58)
Neuroscience (2708)
NextGen: Class of 2026 (4867)
Non-profit (2927)
Now hiring (18)
Obesity (466)
Opinion (131)
Ovarian cancer (203)
Pain (212)
Pancreatic cancer (262)
Parkinson's disease (327)
Partnered (24)
Patents (520)
Patient recruitment (627)
Peanut (49)
People (53622)
Pharmaceutical (40)
Pharmacy benefit managers (20)
Phase 1 (19036)
Phase 2 (27482)
Phase 3 (20323)
Pipeline (8586)
Policy (174)
Postmarket research (2316)
Preclinical (8071)
Press Release (57)
Prostate cancer (267)
Psychedelics (27)
Radiopharmaceuticals (263)
Rare diseases (855)
Real estate (4500)
Recruiting (42)
Regulatory (20539)
Reports (29)
Research institute (1704)
Resumes & cover letters (148)
Rett syndrome (43)
RNA editing (10)
RSV (71)
Schizophrenia (143)
Series A (231)
Series B (175)
Service/supplier (4)
Sickle cell disease (89)
Special edition (3)
Spinal muscular atrophy (125)
Sponsored (27)
Startups (2905)
Stomach cancer (11)
Supply chain (84)
Tariffs (34)
The Weekly (21)
Vaccines (782)
Venture capital (59)
Weight loss (250)
Women's health (100)
Worklife (13)
Date
Today (60)
Last 7 days (374)
Last 30 days (1528)
Last 365 days (24966)
2026 (14024)
2025 (24922)
2024 (29122)
2023 (33534)
2022 (42940)
2021 (46784)
2020 (44090)
2019 (35838)
2018 (27062)
2017 (26562)
2016 (25883)
2015 (32523)
2014 (27406)
2013 (23090)
2012 (25189)
2011 (25913)
2010 (24594)
Location
Africa (562)
Alabama (77)
Alaska (5)
Arizona (332)
Arkansas (11)
Asia (32533)
Australia (5184)
California (12634)
Canada (3419)
China (1199)
Colorado (523)
Connecticut (460)
Delaware (315)
Europe (67339)
Florida (1913)
Georgia (405)
Hawaii (3)
Idaho (52)
Illinois (931)
India (76)
Indiana (501)
Iowa (17)
Japan (559)
Kansas (116)
Kentucky (39)
Louisiana (38)
Maine (80)
Maryland (1401)
Massachusetts (8819)
Michigan (348)
Minnesota (679)
Mississippi (4)
Missouri (108)
Montana (25)
Nebraska (22)
Nevada (123)
New Hampshire (74)
New Jersey (3190)
New Mexico (20)
New York (3194)
North Carolina (1509)
North Dakota (6)
Northern California (6327)
Ohio (341)
Oklahoma (20)
Oregon (22)
Pennsylvania (2428)
Puerto Rico (24)
Rhode Island (32)
South America (873)
South Carolina (81)
South Dakota (1)
Southern California (5155)
Tennessee (154)
Texas (2073)
United States (43389)
Utah (370)
Vermont (1)
Virginia (213)
Washington D.C. (52)
Washington State (989)
West Virginia (1)
Wisconsin (102)
Wyoming (2)
625,840 Results for "icon group international inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ICON Reports First Quarter 2026 Results
June 24, 2026
·
14 min read
Press Releases
Icon Group Deploys ChartCheck Adaptive Across Australia as Radformation Secures USFDA 510(k) Clearance
February 18, 2026
·
4 min read
Sponsored
Accelerating Timelines and Reducing Cost in Early Clinical Drug Development With ICON’s Accelerated Pharmaceutical Solutions
Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced formulation design, real-time dose flexibility, and cutting-edge CMC expertise to transform complexity into clarity. By uniting science, technology, and strategy, biotechs can move faster, smarter, and with confidence—turning obstacles into opportunities for breakthrough success.
December 8, 2025
·
5 min read
·
Arjen Akkerman
Press Releases
ICON Schedules First Quarter 2026 Earnings Conference Call
June 18, 2026
·
3 min read
Press Releases
Colossal Biosciences Expands De-extinction Portfolio with Iconic Bluebuck
April 30, 2026
·
20 min read
Press Releases
ICON expands US early phase research capabilities with new clinic and outpatient centres
May 13, 2026
·
3 min read
Press Releases
ICON Reports Fourth Quarter and Full Year 2025 Results and Provides Outcome of Audit Committee Investigation
May 28, 2026
·
20 min read
Press Releases
ICON’s Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership
January 27, 2026
·
3 min read
Earnings
Vertex’s quiet Q1 is calm before potentially ‘iconic’ renal evolution
While some analysts may regard Vertex Pharmaceuticals’ first quarter results as “unremarkable,” BMO Capital Markets wrote on Monday, the second half of 2026 could be big for the biotech, with the potential approval of IgAN therapy povetacicept.
May 5, 2026
·
2 min read
·
Tristan Manalac
Press Releases
International Myeloma Foundation (IMF) and International Myeloma Working Group (IMWG) to Honor 2026 Kyle and Durie Achievement Awardees, Dr. Hermann Einsele and Dr. Noopur Raje
June 9, 2026
·
8 min read
1 of 62,584
Next
